CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-14 | Novo Holdings A/S 10% owner | Conversion · SERIES B CONVERTIBLE PREFERRED STOCK | −10,000,000 | 0 | ||
| 2020-10-14 | Muralidhar Bali Director | Conversion | +1,592,518 | 1,592,518 | ||
| 2020-10-14 | Muralidhar Bali Director | Purchase | +200,000 | $15.00 | $3.0M | 1,792,518 |
| 2020-10-14 | Muralidhar Bali Director | Conversion · Series B Preferred Stock | −10,416,666 | 0 | ||
| 2020-10-14 | O'Donnell Niall Director | Conversion | +445,905 | 445,905 | ||
| 2020-10-14 | O'Donnell Niall Director | Purchase | +250,000 | $15.00 | $3.8M | 695,905 |
| 2020-10-14 | O'Donnell Niall Director | Conversion · Series B Preferred Stock | −2,916,664 | 0 | ||
| 2020-10-14 | Omega Fund VI, L.P. Former 10% Owner | Conversion | +1,911,022 | 1,911,022 | ||
| 2020-10-14 | Omega Fund VI, L.P. Former 10% Owner | Purchase | +250,000 | $15.00 | $3.8M | 2,161,022 |
| 2020-10-14 | Omega Fund VI, L.P. Former 10% Owner | Conversion · Series B Preferred Stock | −12,500,000 | 0 | ||
| 2020-10-14 | Chaya Moghrabi Dina Director | Conversion | +1,911,022 | 1,911,022 | ||
| 2020-10-14 | Chaya Moghrabi Dina Director | Purchase | +250,000 | $15.00 | $3.8M | 2,161,022 |
| 2020-10-14 | Chaya Moghrabi Dina Director | Conversion · Series B Preferred Stock | −12,500,000 | 0 | ||
| 2020-10-14 | HealthCap VIII, L.P. Former 10% Owner | Conversion | +1,783,621 | 1,783,621 | ||
| 2020-10-14 | HealthCap VIII, L.P. Former 10% Owner | Purchase | +250,000 | $15.00 | $3.8M | 2,033,621 |
| 2020-10-14 | HealthCap VIII, L.P. Former 10% Owner | Conversion · Series B Preferred Stock | −11,666,666 | 0 | ||
| 2020-10-14 | HANSSON JONAS Director | Conversion | +1,783,621 | 1,783,621 | ||
| 2020-10-14 | HANSSON JONAS Director | Purchase | +250,000 | $15.00 | $3.8M | 2,033,621 |
| 2020-10-14 | HANSSON JONAS Director | Conversion · Series B Preferred Stock | −11,666,666 | 0 | ||
| 2020-10-14 | RiverVest Venture Fund III, L.P. 10% owner | Conversion | +1,070,172 | 1,070,172 |
Page 13 of 14 · 264 trades